Takeda Pharmaceutical Company Ltd

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)

Completed

Conditions: Anaplastic Lymphoma Kinase
Carcinoma, Non-Small-Cell Lung

Interventions: Other: No Intervention

First Posted Date: 2021-05-14

Last Posted Date: 2023-04-18

Lead Sponsor: Takeda

Target Recruit Count: 39

Registration Number: NCT04887519

Locations: 🇦🇷
IC Projects, Buenos Aires, Argentina

A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)

Completed

Conditions: Inflammatory Bowel Diseases
Crohns Disease
Colitis, Ulcerative

First Posted Date: 2021-05-13

Last Posted Date: 2024-04-16

Lead Sponsor: Takeda

Target Recruit Count: 120

Registration Number: NCT04885920

Locations: 🇭🇷
Klinicki bolnicki centar Osijek (University medical centre Osijek), Osijek, Croatia
🇭🇷
Klinicki bolnicki centar Rijeka (University medical centre Rijeka), Rijeka, Croatia
🇸🇮
Univerzitetni klinicni center Ljubljana (University medical Centre Ljubljana), Ljubljana, Slovenia

and more 5 locations

A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

Completed

Conditions: Short Bowel Syndrome

First Posted Date: 2021-05-12

Last Posted Date: 2023-08-31

Lead Sponsor: Takeda

Target Recruit Count: 65

Registration Number: NCT04883606

Locations: 🇪🇸
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Phase 1

Completed

Conditions: Squamous Cell Carcinoma of Head and Neck
Carcinoma, Non-Small-Cell Lung
Triple Negative Breast Neoplasms

Interventions: Drug: Pembrolizumab
Drug: TAK-676
Radiation: Image-guided radiation therapy

First Posted Date: 2021-05-10

Last Posted Date: 2024-06-11

Lead Sponsor: Takeda

Target Recruit Count: 34

Registration Number: NCT04879849

Locations: 🇺🇸
Cedars Sinai Medical Center, Duarte, California, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States

and more 2 locations

A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

Completed

Conditions: Short Bowel Syndrome

First Posted Date: 2021-05-07

Last Posted Date: 2023-07-19

Lead Sponsor: Takeda

Target Recruit Count: 45

Registration Number: NCT04877431

Locations: 🇦🇷
IC Projects, Buenos Aires, Argentina

A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas

Completed

Conditions: Crohn Disease
Rectal Fistula

First Posted Date: 2021-05-06

Last Posted Date: 2024-08-05

Lead Sponsor: Takeda

Target Recruit Count: 15

Registration Number: NCT04876690

Locations: 🇵🇹
Centro Hospitalar Universitario de Lisboa Central (CHULC), Lisboa, Portugal
🇵🇹
Centro Hospitalar Tondela-Viseu (CHTV), Viseu, Portugal
🇵🇹
Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal

and more 2 locations

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

Completed

Conditions: Hemophilia A

Interventions: Other: Non-Interventional

First Posted Date: 2021-05-06

Last Posted Date: 2023-07-24

Lead Sponsor: Takeda

Target Recruit Count: 153

Registration Number: NCT04876365

Locations: 🇨🇦
Hamilton-Niagara Regional Hemophilia Treatment Centre, Hamilton, Ontario, Canada

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

Completed

Conditions: Inflammatory Bowel Diseases
Colitis, Ulcerative
Crohn Disease

First Posted Date: 2021-05-05

Last Posted Date: 2024-11-07

Lead Sponsor: Takeda

Target Recruit Count: 335

Registration Number: NCT04873700

Locations: 🇲🇽
Unidad de Enfermedades Reumaticas y Cronico degenerativas, Torreon, Coahuila, Mexico
🇲🇽
Centro De Investigacion Clinica De Alta Especialidad "Cicae", Torreon, Coahuila, Mexico
🇲🇽
Hospital Medica Sur Tlalpan, Ciudad de Mexico, Distrito Federal, Mexico

and more 9 locations

A Study of Vedolizumab in Adults in Real-World Practice

Completed

Conditions: Colitis, Ulcerative
Crohn Disease

First Posted Date: 2021-05-04

Last Posted Date: 2024-07-22

Lead Sponsor: Takeda

Target Recruit Count: 500

Registration Number: NCT04872491

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

and more 37 locations

Post-Marketing Study of Prucalopride Safety In Pregnancy

Recruiting

Conditions: Chronic Idiopathic Constipation (CIC)

Interventions: Other: No Intervention

First Posted Date: 2021-05-03

Last Posted Date: 2024-06-28

Lead Sponsor: Takeda

Target Recruit Count: 616

Registration Number: NCT04869280

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy